维普期刊资源整合服务平台（V6.5）

190篇 您的检索式：作者名="Burstein H"

选中清除导出查看参考文献查看引证文献引用追踪共10页首页上一页第1页下一页末页 /10 跳转

	题名	作者	年代	出处	被引量
1	Randomized study of lapatinib alone or in combination with trastuzumab in women with ErbB2 positive, trastuzumab refractory metastatic breast cancer 显示文摘	Blackwell KL Burstein H J Storniolo AM	2010	J Clin Oncol2010，28，7：	1
2	Viral aetiology of hemangiosarcoma outbreaks among layer hens显示文摘	BURSTEIN H GILEAD M BENDHEIM U at al	1984	Avian Pathology1984，13，4：	1
3	Phase II study of sunitinib malate, an oral multi-targeted tyrosine kinas inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane 显示文摘	Burstein H J Elias A D Rugo H S	2008	JClin Oncol2008，26，11：	1
4	The effects of bicarbonate on the corrosion and passivation of iron显示文摘	D H Davies G T Burstein	1980	Corrosion1980，36，8：	1
5	Trastuzumab plus vinorelbine or taxane chemotherapy for HER2-overexpressing metastatic breast cancer: the trastuzumab and vinorelbine or taxane study显示文摘	Burstein H J Keshaviah A Baron AD	2007	Cancer2007，1110，5：	1
6	The Effects of Bicarbonate on the Corrosion and Passivation of Iron显示文摘	Davies D H Burstein G T	1980	Corrosion1980，36，8：	1
7	Preoperative therapy in invasive breast cancer:pathologic assessment and systemic therapy issues in operable disease显示文摘	Gralow JR Burstein H J Wood W	2008	J Clin Oncol2008，26，5：	1
8	A randomized study of lapatinib alone or in combination with trastuzumab in heavily pretreated HER2 + metastatic breast cancer progressing on trastzumab therapy 显示文摘	O'Shaughnessy J Blackwell KL Burstein H	2008	J Clin Oncol2008，26，15：	1
9	Prospective evaluation of concurrent paclitaxel and radiation therapy after adjuvant doxorubicin and cyclophosphamide chemotherapy for Stage Ⅱ or Ⅲ breast cancer显示文摘	Burstein H J Bellon J R Galper S	2006	Int J Radiat Oncol Biol Phys2006，64，2：	1
10	American Society of Clinical Oncology clinical practice guideline:update on adjuvant endocrine therapy for women with hormone receptor - positive breast cancer显示文摘	Burstein H J Prestrud AA Seidenfeld J	2010	J Clin Onco12010，28，23：	1
11	Phase II study of suni- tinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane 显示文摘	Burstein H J Elias AD Rugo HS	2008	J Clin Oncol2008，26，11：	1
12	Ontology translation for interoperability among semantic Web services显示文摘	Burstein M H McDermott D V	2005	AI Magazine2005，26，1：	1
13	Phase II study of sunitinib malate,an oral multitargeted tyrosine kinase inhibitor,in patients with metastatic breast cancer previously treated with an anthracycline and a taxane显示文摘	Burstein H J Elias AD Rugo HS	2008	J Clin Oncol2008，26，11：	1
14	Gene therapy for rheumatoid arthritis 显示文摘	Burstein H	2001	Curr Opi Mol Ther2001，3，4：	1
15	Nerainib,an irreversible Erb B receptor tyrosine kinase inhibitor,in patients with advanced Erb B2-positive breast cancer显示文摘	Burstein H J Sun Y Dirix L Y	2010	J Clin Oncol2010，28，8：	1
16	Distinctive nature of HER-2 postive breast cancers显示文摘	Burstein H	2006	New Engl J Med2006，353，16：	1
17	The Effects of bicarbonate on the corrosion and passivation of iron显示文摘	Davies D H Burstein G T	1980	Corrosion1980，36，8：	1
18	A framework for dynamic information flow in mixed-initiative human/agent organizations 显示文摘	M H Burstein D E Diller	2004	Applied Intelligence (S 1573-7497)2004，20，3：	1
19	A phase Ⅱ study of lapatinib monotherapy in chemotherapy - refractory HER2 - positive and HER2 - negative advanced or metastatic breast cancer显示文摘	BURSTEIN H J STORNIOLO A M FRANCO S	2008	Ann Oncology2008，19，6：	1
20	Viral aetiology of hemangiosarcoma outbreaks among layer hens 显示文摘	BURSTEIN H GILEAD M BENDHEIM U	1984	Avian Pathol1984，13，：	1

返回顶部每页显示：

共10页首页上一页第1页下一页末页 /10 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示